PER 2.30% 8.5¢ percheron therapeutics limited

Ann: Trial Met Primary & Exceeded Secondary Endpoint Expectations, page-178

  1. 7,434 Posts.
    lightbulb Created with Sketch. 532
    I think pumper are worst. But as i said Anp doesn't have a phase 2 drug. Hench phase 2b. Dripping sp
    counter. They cant continue to phase 3.
    sp. 4 to 5c next 2 years.
    share price. Could jump to 10 to 15c but with aef unloading for next CR you guys be lucky to hold above 10c more than a week.

    note. Every firm knows this is a long game.
    they not going rush in n push the sp in a panic buying.

    also traders know that aef is saleing so they not going rush in n pump this stock n get caught out by aef n platinum n long term holders wanting out.

    anp is bit of a pickle. They could pump the sp to new highights like a j.v but any deal before phase 2b would be worst than a CR at 6c to 5c
    Last edited by markie125: 06/06/20
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.5¢
Change
-0.002(2.30%)
Mkt cap ! $76.63M
Open High Low Value Volume
9.0¢ 9.2¢ 8.5¢ $81.76K 928.3K

Buyers (Bids)

No. Vol. Price($)
4 189228 8.5¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 10352 1
View Market Depth
Last trade - 16.10pm 06/06/2024 (20 minute delay) ?
Last
9.0¢
  Change
-0.002 ( 2.27 %)
Open High Low Volume
9.0¢ 9.0¢ 9.0¢ 1
Last updated 10.35am 06/06/2024 ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.